Navigation Links
GEN Reports on Novel Hit-to-Lead Drug Discovery Strategies
Date:7/8/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... REDWOOD CITY , Kalifornien und HILDEN, ... QIAGEN Clinical Insight ... Interpretation von Genvarianten und die Erstellung dazugehöriger ... und ESHG     QIAGEN N.V. ... QIA) gab heute die Markteinführung von QIAGEN ...
(Date:5/26/2015)... China , May 26, 2015 Tianyin ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), announced that the Company,s Annual Meeting of Shareholders ... scheduled to be held at the Company,s office located ... conference call, at 9:00 AM (local time in ...
(Date:5/26/2015)... , May 26, 2015 Pharmaco-Kinesis Corporation (PKC) ... recently convened at Shutters on the Beach in ... development status of the Company,s innovative Metronomic Biofeedback Pump ... locally deliver chemotherapy over time to a target site ... capacity and biofeedback system in real-time.  ...
(Date:5/26/2015)... 2015 Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug delivery ... protocol for the company,s Phase IIb trial of ORMD-0801, ... Drug Administration (FDA). The submission was made under the ... The Phase IIb study of ORMD-0801 for type 2 ...
Breaking Biology Technology:QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 2QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 3QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 4QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 5QIAGEN bringt klinische Bioinformatik-Plattform für Next Generation Sequencing-Anwendungen auf den Markt 6TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 2Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 3Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 4Pharmaco-Kinesis Corporation Convenes Third Neuro-Oncology Clinical Advisory Board Meeting 5Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 2Oramed Submits Protocol to U.S. FDA for Its Phase IIb Oral Insulin Study 3
... American Society of Clinical Oncology (ASCO) Meeting Show Fleximer(R) ... Prolonged Stable Disease in Refractory Tumors - , ... preliminary results of a Phase 1 clinical trial for ... at the 2009 Annual Meeting of the American Society ...
... , - Webinar on June 9 to discuss the prevalence ... at www.connecttoprotect.com - , ... Gastroenterological Association (AGA) Institute and Horizon Therapeutics, Inc. today launched ... about the gastrointestinal (GI) risks associated with the use of ...
... CHICAGO, June 1 UCB, Inc. and the ... of the 2009 Research Awards in Inflammatory Bowel Disease (IBD) ... research grant for their original clinical or basic research, totaling ... the CDWG Steering Committee and the awards were funded by ...
Cached Biology Technology:Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 2Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors 3AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 2AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 3UCB and Crohn's Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows 2
(Date:5/26/2015)... 26, 2015 Research and ... of the "Saudi Arabia Biometric Systems Market ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The biometric systems ... is projected to grow at over 22% CAGR ... attributed to the surging demand for better biometric ...
(Date:5/25/2015)... SYDNEY , May 25, 2015  Australia,s market ... inception stage, although 2014 saw the advent of several ... on 24 April 2015 is expected to ignite interest ... devices in Australia . This in ... the industry and drive new partnerships amongst vendors and ...
(Date:5/22/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... ending its promotional pricing and making the Wocket generally available ... Savin , Head of Marketing said, "We,ve extended the opportunity ... end of May. To get your wocket at this special ... the store on June 1, you,ll receive a unique code ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... many aspects of who we are from the colour ... but how are the genes, and consequently the proteins they ... new group of molecules which control some of the fundamental ... developing new therapies for treating neurodegenerative diseases. The research, ...
... paper published today in Nature,s open access journal Scientific ... that male pseudoscorpions treated with the antibiotic tetracycline suffer significantly ... their untreated sons. They suggest that a similar effect could ... first research to show a transgenerational effect of antibiotics," David ...
... April 27, 2012 Aware, Inc. (NASDAQ: AWRE ), ... today reported financial results for its first quarter ended March 31, ... were $5.7 million, a decrease of 10% compared to $6.4 million ... quarter of 2012 was $1.1 million, or $0.05 per diluted share. ...
Cached Biology News:Doubling the information from the double helix 2University of Nevada, Reno first to show transgenerational effect of antibiotics 2Aware, Inc. Reports First Quarter 2012 Financial Results 2Aware, Inc. Reports First Quarter 2012 Financial Results 3Aware, Inc. Reports First Quarter 2012 Financial Results 4Aware, Inc. Reports First Quarter 2012 Financial Results 5
Porcine TNF-alpha/TNFSF1A ELISpot Development Module...
Request Info...
Services include subcloning into an expression vector. Tagged protein will be expressed in small scale for testing yield and solubility and then in 1L culture for large scale affinity purification. E...
...
Biology Products: